Skip to main content

Table 5 MMSE Total Raw Score by Subject and Visit– ITT Population

From: Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study

Cohort

Subject

AD Severity Stage

Baseline

Week 11/ Visit 5

Week 22/ EOS

Score

Score

CFB

Score

CFB

1

002

moderate

14

11

-3

11

-3

003

moderate

13

13

0

17

4

004

mild

13

12

-1

13

0

005

mild

23

19

-4

16

-7

2

006

severe

14

11

-3

np

 

007

mild

19

17

-2

17

-2

009

severe

3

np

 

np

 

011

mild

21

20

-1

20

-1

3

012

severe

2

1

-1

1

-1

014

moderate

14

23

9

23

9

015

mild

21

13

-8

14

-7

Medians (IQR)

14.0 

(13.0,21.0)

13.0 

(11.0,19.3)

-1.5 

(-3.3,-0.8)

16.0

(12.0,18.5)

-1.0 

(-5.0, 2.0)

  1. CFB: change from baseline; np: not performed; IQR: interquartile range